| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review
|
Adair, Olivia
|
|
|
28 |
5 |
p. 790-799
|
artikel
|
| 2 |
An Acquired Taste: Latent Class Analysis to Compare Adolescent and Adult Preferences for EQ-5D-Y-3L Health States
|
Nazari, Jonathan L.
|
|
|
28 |
5 |
p. 781-789
|
artikel
|
| 3 |
Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia
|
Okafor, Charles Ebuka
|
|
|
28 |
5 |
p. 730-741
|
artikel
|
| 4 |
Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People With Diabetes
|
Niu, Shu
|
|
|
28 |
5 |
p. 762-768
|
artikel
|
| 5 |
Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases
|
Xu, Richard Huan
|
|
|
28 |
5 |
p. 769-780
|
artikel
|
| 6 |
Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review
|
Hong, Tianqi
|
|
|
28 |
5 |
p. 800-811
|
artikel
|
| 7 |
Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer
|
Fu, Jinjing
|
|
|
28 |
5 |
p. 720-729
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
28 |
5 |
p. v
|
artikel
|
| 9 |
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
|
Toro, Walter
|
|
|
28 |
5 |
p. 686-691
|
artikel
|
| 10 |
How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report
|
Kakehi, Sumie
|
|
|
28 |
5 |
p. 671-675
|
artikel
|
| 11 |
Managing Uncomplicated Singleton Breech Pregnancy Using the OptiBreech Collaborative Care Pathway: Early Economic Model and Value of Information Analysis
|
Shetty, Siddesh S.
|
|
|
28 |
5 |
p. 751-761
|
artikel
|
| 12 |
Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis
|
Lv, Lei
|
|
|
28 |
5 |
p. 712-719
|
artikel
|
| 13 |
Public Health Supports Whole Health
|
Fountain, Alison
|
|
|
28 |
5 |
p. 709-711
|
artikel
|
| 14 |
Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions
|
Gentilini, Arianna
|
|
|
28 |
5 |
p. 680-685
|
artikel
|
| 15 |
Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions
|
Borah, Bijan J.
|
|
|
28 |
5 |
p. 676-679
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
28 |
5 |
p. i-iv
|
artikel
|
| 17 |
Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health
|
Pizzi, Laura T.
|
|
|
28 |
5 |
p. 702-704
|
artikel
|
| 18 |
The Price Effects of Biosimilars in the United States
|
Jofre-Bonet, Mireia
|
|
|
28 |
5 |
p. 742-750
|
artikel
|
| 19 |
Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
|
van den Berg, Sibren
|
|
|
28 |
5 |
p. 692-698
|
artikel
|
| 20 |
What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research?
|
Devlin, Nancy J.
|
|
|
28 |
5 |
p. 699-701
|
artikel
|
| 21 |
Whole Health: A Global Perspective
|
Nabyonga-Orem, Juliet
|
|
|
28 |
5 |
p. 705-708
|
artikel
|
Tijdschrift beschrijving